University of Kentucky sues CVS over alleged diversion of 340B revenue
The University of Kentucky sued CVS Health in federal court on October 27, alleging that CVS and its subsidiaries diverted more than $41 million in 340B prescription savings over five years. The university claims CVS charged its hospitals full prices instead of applying agreed discounts, retained the savings, and committed fraud, racketeering and breach of contract. CVS said it remains committed to the 340B program, while the university seeks financial damages and other relief.
Why it matters
The case could expose CVS to repayment claims, treble damages, legal fees and contract-related remedies if the allegations succeed. CVS has not filed a court response in the materials, although its spokesperson said the company remains focused on supporting underserved patients and collaborating with health systems.
Key facts
- 1The University of Kentucky filed the federal lawsuit against CVS Health on October 27. finance.yahoo.com
- 2The university alleges CVS diverted more than $41 million in 340B savings over five years. lpm.org
- 3The disputed arrangements covered UK hospitals in Lexington and Ashland and allowed them to buy prescription drugs at discounted prices. lpm.org
- 4The university alleges CVS ended the 340B agreements in April after UK sought records for an audit. lpm.org
- 5UK is seeking three times the allegedly diverted amount, returned profits, access to records, damages and legal fees. lpm.org
Open questions
- The allegations remain unresolved, and the materials do not include CVS's filed court response.
Summary written by AlphAI AI Desk from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.